Drug
Fluticasone Furoate Actuation Nasal Spray
Fluticasone Furoate Actuation Nasal Spray: highest development phase Phase 3, developed by Sandoz. 1 trial record tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Sandoz
Trials
| Drug | Phase | Indication |
|---|---|---|
| Fluticasone furoate 27.5 mcg/actuation nasal spray (Lek Pharmaceuticals) NCT01279057 | Phase 3 | Rhinitis, Allergic, Seasonal |
Latest
No recent events.
Follow Fluticasone Furoate Actuation Nasal Spray on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.